|
Form Serial Number: |
DA20200529E00040
|
1.
Date of relevant event: |
26/05/2020 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
03681 |
4.
Name of listed corporation: |
SinoMab BioScience Ltd. - B |
5.
Class of shares: |
Ordinary Shares |
6.
Number of issued shares in class: |
1,006,240,400 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
LEUNG |
(Other names) |
Shui On |
|
|
|
10.
Name of director (Chinese): |
梁瑞安 |
11.
Chinese Character Code as printed on HKID Card: |
273338431344 |
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1316 | There has been a change in nature of your interest in the shares because: any other event (you must briefly describe the relevant event in the Supplementary Information box) | |
2401 | A concert party to an agreement to buy shares described in s.317(1)(a) | |
2501 | Other (you must describe the capacity in the Supplementary Information box) | |
41,331,640 |
HKD |
|
|
3.5000 |
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 389,469,200 | 38.71 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 389,469,200 | 38.71 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2201 | Interest of corporation controlled by you |
| |
2401 | A concert party to an agreement to buy shares described in s.317(1)(a) |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Skytech Technology Limited | Sea Meadow House, Blackburne Highway, PO Box 116, Road Town, Tortola, British Virgin Islands | Shui On LEUNG | 100.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
Skytech Technology Limited | Addresses of individuals are not displayed. | 178,843,600 |
Forbest Capital Investment Group Limited | Addresses of individuals are not displayed. | 199,476,400 |
Kwan Yin SIU | Addresses of individuals are not displayed. | 1,340,000 |
Ming Hon YAU | Addresses of individuals are not displayed. | 2,000,000 |
Ka Wa Benny CHEUNG | Addresses of individuals are not displayed. | 1,340,000 |
Kwan Yeung LEE | Addresses of individuals are not displayed. | 1,060,000 |
Chau Yin Janet TSUI | Addresses of individuals are not displayed. | 4,349,200 |
Guolin XU | Addresses of individuals are not displayed. | 1,060,000 |
Total number of shares in which a director is interested under sections 317 and 318 | 210,625,600 |
|
|
34.
Supplementary information: |
Pursuant to the Sale and Purchase Agreement dated 26 May 2020 made between, among others, Forbest Capital Investment Group Limited ("Forbest Capital") and Grogene Technology Limited ("Grogene"), Forbest Capital agreed to sell 41,331,640 shares of SinoMab BioScience Limited to Grogene at a price of HK$3.50 per share. Completion of the said Agreement is conditional upon all the Conditions (as defined threin) having been satisfied as stipulated therein.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
1
A0000000000000568022.pdf
|
Date of filing this Form 3A: |
29/05/2020 (dd/mm/yyyy)
|
|